+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Sugammadex"

Global and Chinese Sugammadex Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Sugammadex Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 139 Pages
  • China, Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Sugammadex is a neuromuscular blocking agent used in anesthetic drugs. It is a modified gamma-cyclodextrin molecule that binds to and reverses the effects of rocuronium and vecuronium, two commonly used neuromuscular blocking agents. It is used to facilitate rapid recovery from neuromuscular blockade, allowing for a shorter duration of anesthesia and a quicker return to normal activities. Sugammadex is administered intravenously and is available in both a powder and a solution form. The Sugammadex market is composed of a variety of companies that produce and distribute the drug. These companies include Merck, Fresenius Kabi, Baxter, and Mylan. Additionally, there are several generic manufacturers that produce and distribute the drug. These companies include Teva Pharmaceuticals, Sandoz, and Apotex. Show Less Read more